• Non ci sono risultati.

DIAGNOSTIC INVESTIGATIONS CLINICAL FEATURES GENETICS/BASIC DEFECTS Achondrogenesis

N/A
N/A
Protected

Academic year: 2022

Condividi "DIAGNOSTIC INVESTIGATIONS CLINICAL FEATURES GENETICS/BASIC DEFECTS Achondrogenesis"

Copied!
8
0
0

Testo completo

(1)

Achondrogenesis is a heterogeneous group of lethal chon- drodysplasias. Achondrogenesis type I (Fraccaro-Houston-Harris type) and type II (Langer-Saldino type) were distinguished on the basis of radiological and histological criteria. Achondrogenesis type I was further subdivided, on the basis of convincing histo- logical criteria, into type IA, which has apparently normal car- tilage matrix but inclusions in chondrocytes, and type IB, which has an abnormal cartilage matrix. Classification of type IB as a separate group has been confirmed recently by the dis- covery of its association with mutations in the diastrophic dys- plasia sulfate transporter (DTDST) gene, making it allelic with diastrophic dysplasia.

GENETICS/BASIC DEFECTS

1. Type IA: an autosomal recessive disorder with an unknown chromosomal locus

2. Type IB

a. An autosomal recessive disorder

b. Resulting from mutations of the DTDST gene, which is located at 5q32-q33

3. Type II

a. Autosomal dominant type II collagenopathy

b. Resulting from mutations in the COL2A1 gene, which is located at 12q13.1-q13.3

CLINICAL FEATURES

1. Prenatal/perinatal history a. Polyhydramnios b. Hydrops

c. Breech presentation d. Perinatal death 2. Achondrogenesis type I

a. Growth

i. Lethal neonatal dwarfism ii. Mean birth weight of 1200 g b. Craniofacial features

i. Disproportionately large head ii. Soft skull

iii. Sloping forehead iv. Convex facial plane

v. Flat nasal bridge, occasionally associated with a deep horizontal groove

vi. Small nose, often with anteverted nostrils vii. Long philtrum

viii. Retrognathia

ix. Increased distance between lower lip and lower edge of chin

x. Double chin appearance c. Extremely short neck d. Thorax

i. Short and barrel-shaped thorax ii. Lung hypoplasia

e. Heart

i. Patent ductus arteriosus ii. Atrial septal defect iii. Ventricular septal defect f. Protuberant abdomen g. Limbs

i. Extremely short (micromelia), shorter than type II ii. Flipper-like appendages

3. Achondrogenesis type II a. Growth

i. Lethal neonatal dwarfism ii. Mean birth weight of 2100 g b. Craniofacial features

i. Disproportionately large head ii. Large and prominent forehead iii. Midfacial hypoplasia

a) Flat facial plane b) Flat nasal bridge

c) Small nose with severely anteverted nostrils iv. Normal philtrum

v. Micrognathia vi. Cleft palate c. Extremely short neck d. Thorax

i. Short and flared thorax ii. Bell-shaped cage iii. Lung hypoplasia e. Protuberant abdomen

f. Extremely short limbs (micromelia)

DIAGNOSTIC INVESTIGATIONS

1. Radiological features a. Variable features

b. No single obligatory feature

c. Distinction between type IA and type IB on radi- ographs not always possible

d. Degree of ossification: age dependent, and caution is needed when comparing radiographs at different ges- tational ages

e. Achondrogenesis type I

i. Skull: Varying degree of deficient cranial ossifi- cation consisting of small islands of bone in membranous calvaria

ii. Thorax and ribs

a) Short and barrel-shaped thorax

b) Thin ribs with marked expansion at costo- chondral junction, frequently with multiple fractures

iii. Spine and pelvis

a) Poorly ossified spine, ischium, and pubis b) Poorly ossified iliac bones with short medial

margins

7

(2)

iv. Limbs and tubular bones

a) Extreme micromelia, with limbs much shorter than in type II

b) Prominent spike-like metaphyseal spurs c) Femur and tibia frequently presenting as

short bone segments

v. Subtype IA (Houston-Harris type) a) Poorly ossified skull

b) Thin ribs with multiple fractures c) Unossified vertebral pedicles d) Arched ilium

e) Hypoplastic but ossified ischium f) Wedged femur with metaphyseal spikes g) Short tibia and fibula with metaphyseal flare vi. Subtype IB (Fraccaro type)

a) Adequately ossified skull b) Absence of rib fractures

c) Total lack of ossification or only rudimentary calcification of the center of the vertebral bodies

d) Ossified vertebral pedicles

e) Iliac bones with ossification only in their upper part, giving a crescent-shaped, “paraglider- like” appearance on X-ray

f) Unossified ischium

g) Shortened tubular bones without recognized axis

h) Metaphyseal spurring giving the appearance of a “thorn apple” or “acanthocyte” (a descrip- tive term in hematology)

i) Trapezoid femur j) Stellate tibia k) Unossified fibula

l) Poorly ossified phalanges f. Achondrogenesis type II

i. Skull

a) Normal cranial ossification b) Relatively large calvaria ii. Thorax and ribs

a) Short and flared thorax b) Bell-shaped cage

c) Shorter ribs without fractures

iii. Spine and pelvis: relatively well-ossified iliac bones with long, crescent-shaped medial and inferior margins

iv. Limbs and tubular bones

a) Short, broad bones, usually with some dia- physeal constriction and flared, cupped metaphyseal ends

b) Metaphyseal spurs, usually smaller than type I 2. Histologic features

a. Achondrogenesis type IA i. Normal cartilage matrix

ii. Absent collagen rings around the chondrocytes iii. Vacuolated chondrocytes

iv. Presence of intrachondrocytic inclusion bodies (periodic acid-Schiff [PAS] stain positive, dia- stase resistant)

v. Extraskeletal cartilage involvement

vi. Enlarged lacunas vii. Woven bone b. Achondrogenesis type IB

i. Abnormal cartilage matrix: presence of

“demasked” coarsened collagen fibers, particu- larly dense around the chondrocytes, forming collagen rings

ii. Abnormal staining properties of cartilage a) Reduced staining with cationic dyes, such as

toluidine blue or Alcian blue, probably because of a deficiency in sulfated proteo- glycans

b) This distinguishes type IB from type IA, in which the matrix is close to normal and inclusions can be seen in chondrocytes, and from achondrogenesis type II, in which cationic dyes give a normal staining pattern c. Achondrogenesis type II

i. Cartilage

a) Slightly larger than normal

b) Grossly distorted (lobulated and mush- roomed)

ii. Markedly deficient cartilaginous matrix iii. Severe disturbance in endochondral ossification

iv. Hypercellular and hypervascular reserve cartilage with large, primitive mesenchymal (ballooned) chondrocytes with abundant clear cytoplasm (vacuoles) (“Swiss cheese-like”)

v. Overgrowth of membranous bones resulting in cupping of the epiphyseal cartilages

vi. Decreased amount and altered structure of pro- teoglycans

vii. Relatively lower content of chondroitin 4-sulfate viii. Lower molecular weight and decreased total

chondroitin sulfation ix. Absence of type II collagen

x. Increased amounts of type I and type III collagen 3. Biochemical testing

a. Lack of sulfate incorporation: cumbersome and not used for diagnostic purposes

b. Sulfate incorporation assay in cultured skin fibrob- lasts or chondrocytes: recommended in the rare instances in which the diagnosis of achondrogenesis type IB is strongly suspected but molecular genetic testing fails to detect SLC26A2 (DTDST) mutations 4. Molecular genetic studies

a. Mutation analysis of the DTDST gene, reported in:

i. Achondrogenesis type IB (the most severe form) ii. Atelosteogenesis type II (an intermediate form) iii. Diastophic dysplasia (the mildest form)

iv. Recessive multiple epiphyseal dysplasia b. Achondrogenesis type IB

i. Mutation analysis: testing of the following four most common SLC26A2 (DTDST) gene muta- tions (mutation detection rate about 60%) a) R279W

b) IVS1+2T>C (“Finnish” mutation) c) delV340

d) R178X

(3)

ii. Sequence analysis of the SLC26A2 (DTDST) coding region (mutation detection rate over 90%) a) Private mutations

b) Common mutations

c. Achondrogenesis type II: mutation analysis of the

COL2A1 gene

GENETIC COUNSELING

1. Recurrence risk a. Patient’s sib

i. Achondrogenesis type IA and type IB (autoso- mal recessive disorders)

a) Recurrence risk: 25%

b) Unaffected sibs of a proband: 2/3 chance of being heterozygotes

ii. Achondrogenesis type II

a) Usually caused by a new dominant muta- tion, in which case recurrence risk is not sig- nificantly increased

b) Asymptomatic carrier parent (germline mutation for a dominant mutation) may be present in the families of affected patients, in which case recurrence risk is 50%

b. Patient’s offspring: lethal entities not surviving to reproduction

2. Prenatal diagnosis a. Ultrasonography

i. Polyhydramnios ii. Fetal hydrops

iii. Disproportionally big head iv. Nuchal edema

v. Cystic hygroma vi. A narrow thorax vii. Short limbs

viii. Poor ossification of vertebral bodies and limb tubular bones (leading to difficulties in determin- ing their length)

ix. Suspect achondrogenesis type I

a) An extremely echo-poor appearance of the skeleton

b) A poorly mineralized skull c) Short limbs

d) Rib fractures b. Molecular genetic studies

i. Prenatal diagnosis of achondrogenesis type IB and type II by mutation analysis of chorionic vil- lus DNA or amniocyte DNA in the first or sec- ond trimester

ii. Achondrogenesis type IB

a) Characterize both alleles of DTDST before- hand

b) Identify the source parent of each allele c) Theoretically, analysis of sulfate incorpora-

tion in chorionic villi might be used for pre- natal diagnosis, but experience is lacking iii. Achondrogenesis type II

a) The affected fetus usually with a new domi- nant mutation of the COL2A1 gene

b) Possible presence of asymptomatic carriers in families of an affected patient

c) Prenatal diagnosis possible if the mutation has been characterized in the affected family 3. Management

a. Supportive care

b. No treatment available for the underlying lethal disorder

REFERENCES

Balakumar K: Antenatal diagnosis of Parenti-Fraccaro type achondrogenesis.

Indian Pediatr 27:496–499, 1990.

Bonafé L, Ballhausen D, Superti-Furga A: Achondrogenesis type 1B. Gene reviews, 2004. http://www.genetests.org

Borochowitz Z, Lachman R, Adomian GE, et al.: Achondrogenesis type I:

delineation of further heterogeneity and identification of two distinct sub- groups. J Pediatr 112:23–31, 1988.

Borochowitz Z, Ornoy A, Lachman R, et al.: Achondrogenesis II-hypochondro- genesis: variability versus heterogeneity. Am J Med Genet 24:273–288, 1986.

Benacerraf B, Osathanondh R, Bieber FR: Achondrogenesis type I: ultrasound diagnosis in utero. J Clin Ultrasound 12:357–359, 1984.

Chen H: Achondrogenesis. Emedicine, 2001. http://www.emedicine.com Chen H: Skeletal dysplasia. Emedicine, 2002. http://www.emedicine.com Chen H, Liu CT, Yang SS: Achondrogenesis: a review with special considera-

tion of achondrogenesis type II (Langer-Saldino). Am J Med Genet 10:379–394, 1981.

Faivre L, Le Merrer M, Douvier S, et al.: Recurrence of achondrogenesis type II within the same family: Evidence for germline mosaicism. Am J Med Genet 126A:308–312, 2004.

Godfrey M, Hollister DW: Type II achondrogenesis-hypochondrogenesis: identi- fication of abnormal type II collagen. Am J Hum Genet 43:904–913, 1988.

Horton WA, Machado MA, Chou JW, et al.: Achondrogenesis type II, abnor- malities of extracellular matrix. Pediatr Res 22:324–329, 1987.

Körkkö J, Cohn DH, Ala-Kokko L, et al.: Widely distributed mutations in the COL2A1 gene produce achondrogenesis type II/hypochondrogenesis.

Am J Med Genet 92:95–100, 2000.

Langer LO, Jr, Spranger JW, Greinacher I, et al.: Thanatophoric dwarfism. A condition confused with achondroplasia in the neonate, with brief com- ments on achondrogenesis and homozygous achondroplasia. Radiology 92:285–294 passim, 1969.

Meizner I, Barnhard Y: Achondrogenesis type I diagnosed by transvaginal ultra- sonography at 13 weeks’ gestation. Am J Obstet Gynecol 173:1620–1622, 1995.

Molz G, Spycher MA: Achondrogenesis type I: light and electron-microscopic studies. Eur J Pediatr 134:69–74, 1980.

Mortier GR, Wilkin DJ, Wilcox WR, et al.: A radiographic, morphologic, bio- chemical and molecular analysis of a case of achondrogenesis type II resulting from substitution for a glycine residue (Gly691>Arg) in the type II collagen trimer. Hum Mol Genet 4:285–288, 1995.

Ornoy A, Sekeles E, Smith P, et al.: Achondrogenesis type I in three sibling fetuses. Scanning and transmission electron microscopic studies. Am J Pathol 82:71–84, 1976.

Smith WL, Breitweiser TD, Dinno N: In utero diagnosis of achondrogenesis, type I. Clin Genet 19:51–54, 1981.

Soothill PW, Vuthiwong C, Rees H: Achondrogenesis type 2 diagnosed by trans- vaginal ultrasound at 12 weeks’ gestation. Prenat Diagn 13:523–528, 1993.

Spranger J: International classification of osteochondrodysplasias. Eur J Pediatr 151:407–415, 1992.

Spranger J, Winterpacht A, Zabel B: The type II collagenopathies: a spectrum of chondrodysplasias. Eur J Pediatr 153:56–65, 1994.

Superti-Furga A: Achondrogenesis type 1B. J Med Genet 33:957–961, 1996.

Superti-Furga A, Hästbacka J, Wilcox WR, et al.: Achondrogenesis type IB is caused by mutations in the diastrophic dysplasia sulphate transporter gene. Nat Genet 12:100–102, 1996.

Superti-Furga A, Rossi A, Steinmann B, et al.: A chondrodysplasia family pro- duced by mutations in the diastrophic dysplasia sulfate transporter gene:

genotype/phenotype correlations. Am J Med Genet 63:144–147, 1996.

(4)

Tongsong T, Srisomboon J, Sudasna J: Prenatal diagnosis of Langer-Saldino achondrogenesis. J Clin Ultrasound 23:56–58, 1995.

van der Harten HJ, Brons JT, Dijkstra PF, et al.: Achondrogenesis-hypochon- drogenesis: the spectrum of chondrogenesis imperfecta. A radiological, ultrasonographic, and histopathologic study of 23 cases. Pediatr Pathol 8:571–597, 1988.

Yang SS, Bernstein J: Letter: Proposed readjustment of eponyms for achondro- genesis. J Pediatr 87:333–334, 1975.

Yang S-S, Heidelberger KP, Brough AJ, et al.: Lethal short-limbed chondrodys- plasia in early infancy. Persp Pediatr Pathol 3:1–40, 1976.

Yang SS, Bernstein J: Achondrogenesis type I. Arch Dis Child 52:253–254, 1977.

Yang SS, Gilbert-Barnes E: Skeletal system. In: Gilbert-Barness E (ed):

Potter’s Pathology of the Fetus and Infant. St Louis: Mosby, 1997, pp 1423–1478.

Yang SS, Brough AJ, Garewal GS, et al.: Two types of heritable lethal achon- drogenesis. J Pediatr 85:796–801, 1974.

Yang SS, Heidelberger KP, Bernstein J: Intracytoplasmic inclusion bodies in the chondrocytes of type I lethal achondrogenesis. Hum Pathol 7:667–673, 1976.

(5)

Fig. 1. A neonate with achondrogenesis type I showing large head, short trunk, and extreme micromelia. Radiograph shows unossified calvarium, vertebral bodies and some pelvic bones. The remaining bones are extremely small. There are multiple rib fractures. The sagit- tal section of the femora and the humeri are similar. An extremely small ossified shaft is capped by a relatively large epiphyseal cartilage at both ends. Photomicrographs of resting cartilage with high magni- fication show many chondrocytes that contain large cytoplasmic inclusions which are within clear vacuoles (Diastase PAS stain).

Electron micrograph shows inclusion as a globular mass of electron dense material. It is within a distended cistern of rough endoplasmic reticulum.

(6)

Fig. 2. Achondrogenesis type II. As in type I, this neonate shows large head, short trunk, and micromelia. Sagittal section of the femur shows much better ossification of the shaft than type I. The cartilage lacks glis- tering appearance due to cartilage matrix deficiency. Photomicrograph of the entire cartilage shows severe deficiency of cartilage matrix. The cartilage canals are large, fibrotic, and stellate in shape. Physeal growth zone is severely retarded.

(7)

Fig. 3. Two infants with achondrogenesis type II showing milder spec- trum of manifestations, bordering the type II and spondyloepiphyseal congenita.

(8)

Fig. 4. A newborn girl with achondrogenesis type II showing large head, midfacial hypoplasia, short neck, small chest, and short limbs. The radi- ographs shows generalized shortening of the long bones of the upper and lower extremities with marked cupping (metaphyseal spurs) at the meta- physeal ends of the bones. This is most evident at the distal ends of the tibia, fibular, radius and ulna, and distal ends of the digits. Radiographs also shows short ribs without fractures and hemivertebrae involving thoracic vertebrae as well as the sacrum. Conformation-sensitive gel electrophoresis analysis indicated a sequence variation in the fragment containing exon 19 and the flanking sequences of the COL2A1 gene (Gly244Asp). Similar mutations in this area have been seen in patients diagnosed with hypochondroplasia and achondrogenesis type II.

Riferimenti

Documenti correlati

A low recurrence risk of having a male sib with hemophilia A if the mother has a normal factor VIII clotting activity and no evidence of her car- rying her son’s FVIII

ii. When the spouse is affected with another domi- nantly inherited skeletal dysplasia caused by a known gene mutation: testing for the known mutation for that skeletal dysplasia

Missense mutations in the TNSALP gene have been observed in some hypophosphatasia kindreds, partic- ularly those families with the more severe perinatal and infantile forms of

Presence of NF1 features (café-au-lait spots, freckling, and peripheral or plexiform neurofi- bromas, and Lisch nodules) in an individual with a segment of the body

Nicolaides KH, Snijders RJM, Chen HH, et al.: Fetal gastrointestinal and abdominal wall defects: Associated malformations and chromosomal abnormalities. Fetal Diagn Ther

somal recessive i. Autosomal recessive ii. Basic defects: absence or defective function of osteoclasts results in defective remodeling of bone with partial or complete obliteration

Jansen T, Romiti R: Progeria infantum (Hutchinson-Gilford syndrome) associ- ated with scleroderma-like lesions and acro-osteolysis: a case report and brief review of the literature..

Cohn DH, Briggs MD, King LM, et al.: Mutations in the cartilage oligomeric matrix protein (COMP) gene in pseudoachondroplasia and multiple epiphyseal dysplasia.. A